Skip to main
IRTC

iRhythm Technologies (IRTC) Stock Forecast & Price Target

iRhythm Technologies (IRTC) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 50%
Buy 42%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

iRhythm Holdings is a digital healthcare company with a strong focus on creating trusted solutions for the detection, prediction, and prevention of disease. Their flagship product, the Zio System, combines a wire-free, patch-based 14-day wearable biosensor with a cloud-based data analytic software, providing clinicians with an efficient and accurate means of diagnosing arrhythmias. With a durable revenue growth profile and steady progress in profitability, there is potential for iRhythm to generate double-digit revenue growth and see further improvement in their margin and operating losses. Potential upside drivers include higher ambulatory cardiac testing volume growth, higher revenue growth, and faster international expansion, while risks include sales execution, increased competition, and negative reimbursement developments. With an estimated 17-18% revenue growth for 2026 and potential growth catalysts in the form of further expansion into new channels and categories, the future looks promising for iRhythm.

Bears say

iRhythm Holdings is facing several potential risks that can negatively impact its financials, including reduced commercial reimbursement rates, increased competition, and negative developments in sales execution and reimbursement. However, the company remains confident in its future growth potential, driven by strong demand for its Zio System and the expansion of its channel partner network. Investors should closely monitor these risks while also considering the potential for upside due to higher testing volume and revenue growth, as well as the company's goal to achieve $1 billion in revenue and 15% EBITDA margin by 2027.

iRhythm Technologies (IRTC) has been analyzed by 12 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 42% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About iRhythm Technologies (IRTC) Forecast

Analysts have given iRhythm Technologies (IRTC) a Buy based on their latest research and market trends.

According to 12 analysts, iRhythm Technologies (IRTC) has a Buy consensus rating as of Jun 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $180.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $180.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

iRhythm Technologies (IRTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.